40 articles, transcripts, and reports
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The...
Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Conference
Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Call dated Feb. 12, 2025 Corporate Participants: Tim Power — Head of Investor Relations Christopher A. Viehbacher —…
Biogen Inc (NASDAQ: BIIB) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Tim Power — Head of Investor Relations Christopher A. Viehbacher —…
Biogen Inc (NASDAQ: BIIB) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Tim Power — Head of Investor Relations Christopher Viehbacher — President…
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion. Net income attributable to…
Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today. Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were down 3% on…
Biogen Inc. (NASDAQ: BIIB) reported its second quarter 2024 earnings results today. Total revenue of $2.5 billion was flat at actual currency and up 1%…
Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today. Total revenue rose 1% year-over-year to $2.53 billion. Revenues grew 3% in constant currency.…
Biogen Inc (NASDAQ:BIIB) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Chuck Triano — Head of Investor Relations Christopher Viehbacher — President and Chief Executive Officer Priya…
